Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | FAP | Q12884 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8213214 | 0.88 | DPP4 (0.51) | DPP4DPP8DPP7DPP9 | |
| SCHEMBL8204342 | 0.87 | DPP4 (0.68) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL8212296 | 0.84 | DPP4 (0.56) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL8217514 | 0.80 | DPP4 (0.55) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL9991047 | 0.78 | DPP4 (0.73) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL9991052 | 0.78 | DPP4 (0.73) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL14960664 | 0.78 | DPP4 (0.73) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL4781924 | 0.78 | DPP4 (0.71) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL8207325 | 0.76 | DPP4 (0.68) | DPP4DPP8DPP7DPP9ACE | |
| SCHEMBL8223890 | 0.75 | DPP4 (0.56) | DPP4DPP8DPP7DPP9ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008040995-A9 | INDAZOLES FOR USE AS DPP-IV INHIBITORS | PEAKDALE MOLECULAR LTD (GB) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008040995-A1 | INDAZOLES FOR USE AS DPP-IV INHIBITORS | PEAKDALE MOLECULAR LIMITED (GB) | 2008-04-10 | — | — | WO | disclosed |